Hardware, Equipment & Parts
Compare Stocks
5 / 10Stock Comparison
SVREW vs LFMD vs CELH vs GKOS vs IRDM
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Pharmaceuticals
Beverages - Non-Alcoholic
Medical - Devices
Telecommunications Services
SVREW vs LFMD vs CELH vs GKOS vs IRDM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Hardware, Equipment & Parts | Medical - Pharmaceuticals | Beverages - Non-Alcoholic | Medical - Devices | Telecommunications Services |
| Market Cap | — | $215M | $8.80B | $7.85B | $4.25B |
| Revenue (TTM) | $1M | $219M | $2.97B | $551M | $876M |
| Net Income (TTM) | $-23M | $-17M | $149M | $-189M | $106M |
| Gross Margin | 4.3% | 86.7% | 49.6% | 78.1% | 62.5% |
| Operating Margin | -18.8% | -5.9% | 10.4% | -15.6% | 25.8% |
| Forward P/E | — | — | 21.3x | — | 36.1x |
| Total Debt | $7M | $6M | $670M | $140M | $1.76B |
| Cash & Equiv. | $13M | $37M | $399M | $91M | $97M |
SVREW vs LFMD vs CELH vs GKOS vs IRDM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 22 | May 26 | Return |
|---|---|---|---|
| SaverOne 2014 Ltd (SVREW) | 100 | 3.3 | -96.7% |
| LifeMD, Inc. (LFMD) | 100 | 220.1 | +120.1% |
| Celsius Holdings, I… (CELH) | 100 | 157.5 | +57.5% |
| Glaukos Corporation (GKOS) | 100 | 295.4 | +195.4% |
| Iridium Communicati… (IRDM) | 100 | 107.0 | +7.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SVREW vs LFMD vs CELH vs GKOS vs IRDM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SVREW ranks third and is worth considering specifically for stability.
- Beta 0.58 vs LFMD's 2.12
LFMD is the clearest fit if your priority is dividends.
- 1.5% yield, vs IRDM's 1.5%, (2 stocks pay no dividend)
CELH is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 85.5%, EPS growth -44.4%, 3Y rev CAGR 56.7%
- 41.3% 10Y total return vs GKOS's 457.1%
- 85.5% revenue growth vs SVREW's -38.1%
- Better valuation composite
GKOS is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.20, Low D/E 21.3%, current ratio 4.69x
IRDM carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 3 yrs, beta 1.05, yield 1.5%
- Beta 1.05, yield 1.5%, current ratio 2.48x
- 12.1% margin vs SVREW's -18.8%
- +55.0% vs LFMD's -43.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 85.5% revenue growth vs SVREW's -38.1% | |
| Value | Better valuation composite | |
| Quality / Margins | 12.1% margin vs SVREW's -18.8% | |
| Stability / Safety | Beta 0.58 vs LFMD's 2.12 | |
| Dividends | 1.5% yield, vs IRDM's 1.5%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +55.0% vs LFMD's -43.9% | |
| Efficiency (ROA) | 4.1% ROA vs SVREW's -95.4%, ROIC 8.0% vs -7.5% |
SVREW vs LFMD vs CELH vs GKOS vs IRDM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
SVREW vs LFMD vs CELH vs GKOS vs IRDM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
IRDM leads in 1 of 6 categories
SVREW leads 0 • LFMD leads 0 • CELH leads 0 • GKOS leads 0 • 5 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
IRDM leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CELH is the larger business by revenue, generating $3.0B annually — 2380.4x SVREW's $1M. IRDM is the more profitable business, keeping 12.1% of every revenue dollar as net income compared to SVREW's -18.8%. On growth, SVREW holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1M | $219M | $3.0B | $551M | $876M |
| EBITDAEarnings before interest/tax | -$23M | -$5M | $336M | -$40M | $439M |
| Net IncomeAfter-tax profit | -$23M | -$17M | $149M | -$189M | $106M |
| Free Cash FlowCash after capex | -$23M | $15M | $293M | -$18M | $305M |
| Gross MarginGross profit ÷ Revenue | +4.3% | +86.7% | +49.6% | +78.1% | +62.5% |
| Operating MarginEBIT ÷ Revenue | -18.8% | -5.9% | +10.4% | -15.6% | +25.8% |
| Net MarginNet income ÷ Revenue | -18.8% | -7.8% | +5.0% | -34.3% | +12.1% |
| FCF MarginFCF ÷ Revenue | -18.5% | +6.8% | +9.9% | -3.4% | +34.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.5% | -23.6% | +137.7% | +41.2% | +1.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +85.7% | -16.0% | +120.0% | -6.3% | -25.9% |
Valuation Metrics
Evenly matched — CELH and IRDM each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 37.9x trailing earnings, IRDM trades at a 72% valuation discount to CELH's 137.0x P/E. On an enterprise value basis, IRDM's 13.3x EV/EBITDA is more attractive than CELH's 18.2x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | — | $215M | $8.8B | $7.9B | $4.2B |
| Enterprise ValueMkt cap + debt − cash | — | $185M | $9.1B | $7.9B | $5.9B |
| Trailing P/EPrice ÷ TTM EPS | — | -19.52x | 137.04x | -40.90x | 37.92x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 21.32x | — | 36.13x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.93x | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 18.22x | — | 13.25x |
| Price / SalesMarket cap ÷ Revenue | — | 1.11x | 3.50x | 15.47x | 4.87x |
| Price / BookPrice ÷ Book value/share | — | 8.75x | 2.76x | 11.69x | 9.37x |
| Price / FCFMarket cap ÷ FCF | — | 33.61x | 27.22x | — | 14.17x |
Profitability & Efficiency
Evenly matched — CELH and IRDM each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
IRDM delivers a 22.8% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $-162 for LFMD. GKOS carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRDM's 3.81x. On the Piotroski fundamental quality scale (0–9), IRDM scores 8/9 vs GKOS's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -139.1% | -162.4% | +6.4% | -26.5% | +22.8% |
| ROA (TTM)Return on assets | -95.4% | -24.3% | +3.1% | -20.1% | +4.1% |
| ROICReturn on invested capital | -7.5% | — | +19.7% | -9.2% | +8.0% |
| ROCEReturn on capital employed | -2.8% | -37.4% | +17.2% | -10.3% | +9.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 5 | 3 | 8 |
| Debt / EquityFinancial leverage | 0.70x | 0.27x | 0.23x | 0.21x | 3.81x |
| Net DebtTotal debt minus cash | -$6M | -$30M | $271M | $49M | $1.7B |
| Cash & Equiv.Liquid assets | $13M | $37M | $399M | $91M | $97M |
| Total DebtShort + long-term debt | $7M | $6M | $670M | $140M | $1.8B |
| Interest CoverageEBIT ÷ Interest expense | -7.79x | -6.48x | 2.92x | -18.69x | 2.67x |
Total Returns (Dividends Reinvested)
Evenly matched — LFMD and CELH and IRDM each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CELH five years ago would be worth $20,941 today (with dividends reinvested), compared to $288 for SVREW. Over the past 12 months, IRDM leads with a +55.0% total return vs LFMD's -43.9%. The 3-year compound annual growth rate (CAGR) favors LFMD at 40.8% vs SVREW's -64.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -32.0% | +28.7% | -28.3% | +21.2% | +127.1% |
| 1-Year ReturnPast 12 months | -41.9% | -43.9% | -4.3% | +52.0% | +55.0% |
| 3-Year ReturnCumulative with dividends | -95.4% | +178.9% | -3.8% | +128.7% | -33.9% |
| 5-Year ReturnCumulative with dividends | -97.1% | -45.8% | +109.4% | +61.5% | +10.7% |
| 10-Year ReturnCumulative with dividends | -97.1% | +220.7% | +4129.6% | +457.1% | +412.1% |
| CAGR (3Y)Annualised 3-year return | -64.2% | +40.8% | -1.3% | +31.7% | -12.9% |
Risk & Volatility
Evenly matched — SVREW and GKOS each lead in 1 of 2 comparable metrics.
Risk & Volatility
SVREW is the less volatile stock with a 0.58 beta — it tends to amplify market swings less than LFMD's 2.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GKOS currently trades 91.4% from its 52-week high vs SVREW's 19.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.58x | 2.12x | 1.29x | 1.20x | 1.05x |
| 52-Week HighHighest price in past year | $0.06 | $15.84 | $66.74 | $146.75 | $44.36 |
| 52-Week LowLowest price in past year | $0.01 | $2.56 | $31.80 | $73.16 | $15.65 |
| % of 52W HighCurrent price vs 52-week peak | +19.5% | +28.3% | +51.3% | +91.4% | +90.6% |
| RSI (14)Momentum oscillator 0–100 | 57.3 | 70.8 | 39.1 | 63.0 | 63.3 |
| Avg Volume (50D)Average daily shares traded | 10K | 1.3M | 7.3M | 678K | 2.3M |
Analyst Outlook
Evenly matched — LFMD and IRDM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: LFMD as "Buy", CELH as "Buy", GKOS as "Buy", IRDM as "Buy". Consensus price targets imply 89.3% upside for LFMD (target: $9) vs -11.7% for IRDM (target: $36). For income investors, LFMD offers the higher dividend yield at 1.53% vs CELH's 0.46%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $8.50 | $59.00 | $146.67 | $35.50 |
| # AnalystsCovering analysts | — | 10 | 22 | 24 | 13 |
| Dividend YieldAnnual dividend ÷ price | — | +1.5% | +0.5% | — | +1.5% |
| Dividend StreakConsecutive years of raises | — | 0 | 1 | — | 3 |
| Dividend / ShareAnnual DPS | — | $0.07 | $0.16 | — | $0.58 |
| Buyback YieldShare repurchases ÷ mkt cap | — | 0.0% | +0.5% | 0.0% | +4.4% |
IRDM leads in 1 of 6 categories — strongest in Income & Cash Flow. 5 categories are tied.
SVREW vs LFMD vs CELH vs GKOS vs IRDM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SVREW or LFMD or CELH or GKOS or IRDM a better buy right now?
For growth investors, Celsius Holdings, Inc.
(CELH) is the stronger pick with 85. 5% revenue growth year-over-year, versus -38. 1% for SaverOne 2014 Ltd (SVREW). Iridium Communications Inc. (IRDM) offers the better valuation at 37. 9x trailing P/E (36. 1x forward), making it the more compelling value choice. Analysts rate LifeMD, Inc. (LFMD) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SVREW or LFMD or CELH or GKOS or IRDM?
On trailing P/E, Iridium Communications Inc.
(IRDM) is the cheapest at 37. 9x versus Celsius Holdings, Inc. at 137. 0x. On forward P/E, Celsius Holdings, Inc. is actually cheaper at 21. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SVREW or LFMD or CELH or GKOS or IRDM?
Over the past 5 years, Celsius Holdings, Inc.
(CELH) delivered a total return of +109. 4%, compared to -97. 1% for SaverOne 2014 Ltd (SVREW). Over 10 years, the gap is even starker: CELH returned +41. 3% versus SVREW's -97. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SVREW or LFMD or CELH or GKOS or IRDM?
By beta (market sensitivity over 5 years), SaverOne 2014 Ltd (SVREW) is the lower-risk stock at 0.
58β versus LifeMD, Inc. 's 2. 12β — meaning LFMD is approximately 265% more volatile than SVREW relative to the S&P 500. On balance sheet safety, Glaukos Corporation (GKOS) carries a lower debt/equity ratio of 21% versus 4% for Iridium Communications Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SVREW or LFMD or CELH or GKOS or IRDM?
By revenue growth (latest reported year), Celsius Holdings, Inc.
(CELH) is pulling ahead at 85. 5% versus -38. 1% for SaverOne 2014 Ltd (SVREW). On earnings-per-share growth, the picture is similar: LifeMD, Inc. grew EPS 56. 6% year-over-year, compared to -44. 4% for Celsius Holdings, Inc.. Over a 3-year CAGR, CELH leads at 56. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SVREW or LFMD or CELH or GKOS or IRDM?
Iridium Communications Inc.
(IRDM) is the more profitable company, earning 13. 1% net margin versus -20. 8% for SaverOne 2014 Ltd — meaning it keeps 13. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IRDM leads at 27. 1% versus -1975. 8% for SVREW. At the gross margin level — before operating expenses — LFMD leads at 79. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SVREW or LFMD or CELH or GKOS or IRDM more undervalued right now?
On forward earnings alone, Celsius Holdings, Inc.
(CELH) trades at 21. 3x forward P/E versus 36. 1x for Iridium Communications Inc. — 14. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LFMD: 89. 3% to $8. 50.
08Which pays a better dividend — SVREW or LFMD or CELH or GKOS or IRDM?
In this comparison, LFMD (1.
5% yield), IRDM (1. 5% yield), CELH (0. 5% yield) pay a dividend. SVREW, GKOS do not pay a meaningful dividend and should not be held primarily for income.
09Is SVREW or LFMD or CELH or GKOS or IRDM better for a retirement portfolio?
For long-horizon retirement investors, Iridium Communications Inc.
(IRDM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 05), 1. 5% yield, +412. 1% 10Y return). LifeMD, Inc. (LFMD) carries a higher beta of 2. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IRDM: +412. 1%, LFMD: +220. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SVREW and LFMD and CELH and GKOS and IRDM?
These companies operate in different sectors (SVREW (Technology) and LFMD (Healthcare) and CELH (Consumer Defensive) and GKOS (Healthcare) and IRDM (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SVREW is a small-cap quality compounder stock; LFMD is a small-cap quality compounder stock; CELH is a small-cap high-growth stock; GKOS is a small-cap high-growth stock; IRDM is a small-cap quality compounder stock. LFMD, IRDM pay a dividend while SVREW, CELH, GKOS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.